Jacks Lee - Nov 27, 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Jacks Lee, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Nov 27, 2023
Transactions value $
$0
Form type
4
Date filed
11/29/2023, 04:49 PM
Previous filing
Jun 16, 2023
Next filing
Jun 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Award $0 +30K $0.00 30K Nov 27, 2023 Common Stock 30K $50.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on November 27, 2024 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.